NCT03638622View on ClinicalTrials.gov

Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral Cancer Cancer.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 10, 2017

Primary Completion Date

October 12, 2020

Study Completion Date

October 12, 2020

Conditions
Oral Cancer
Interventions
COMBINATION_PRODUCT

Photodynamic Therapy

Patients receive aminolevulinic acid (ALA) orally with orange juice in 3 fractions at 0,1,2 hours before undergoing photodynamic therapy using LED based Device on day one.

Trial Locations (1)

202002

J.N. Medical College, Aligarh Muslim University, Aligarh

All Listed Sponsors
collaborator

Jawaharlal Nehru Medical College

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Massachusetts General Hospital

OTHER

NCT03638622 - Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral Cancer Cancer. | Biotech Hunter | Biotech Hunter